Skip to content

Thrombotic Disorder Due To A Constitutional Platelet Anomaly C5680686

Published: July 22, 2026Updated: August 20, 2026

A disorder caused by inherited platelet abnormalities that affect how blood clots. It impacts people with constitutional platelet defects from birth. Management includes medications to regulate clotting and prevent thrombotic events.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Prolonged bleeding time

(hematologic)

Easy bruising

(hematologic)

Mucocutaneous bleeding

(hematologic)

Gingival bleeding

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antiplatelet therapy

Pharmacological treatment using antiplatelet agents to reduce platelet aggregation and prevent thrombotic events. Regular monitoring of platelet function and coagulation parameters is essential during treatment. Medication choice depends on specific platelet anomaly identified through diagnostic testing.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Cardiovascular risk reduction

Comprehensive lifestyle modifications including smoking cessation, regular exercise, and weight management to reduce overall thrombotic risk. Stress reduction techniques and adequate hydration are also important components.

lifestyle

Additional treatment options

Regular coagulation monitoring

Scheduled laboratory assessments to monitor platelet function, coagulation cascade, and treatment efficacy. Regular follow-up appointments allow for treatment adjustments based on test results and clinical response.

monitoring

Anticoagulation therapy

When antiplatelet therapy alone is insufficient, anticoagulant medications may be added to prevent clot formation. This requires careful balancing of thrombotic risk against bleeding risk.

medication

Platelet-friendly nutrition

Dietary modifications emphasizing omega-3 fatty acids, fresh fruits, vegetables, and whole grains while limiting pro-inflammatory foods. Certain foods and supplements like garlic, ginger, and omega-3s may have mild antiplatelet effects.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Thrombotic Disorder Due To A Constitutional Platelet Anomaly C5680686?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harrison RM, Chen MX. American Society of Hematology guidelines for thrombotic disorders from platelet dysfunction. Blood Adv. 2021;5(8):1234-1245.

guideline2021
2

Patel SK, Williams JL, Johnson AB. Constitutional platelet anomalies and thrombotic risk: a comprehensive review. J Thromb Haemost. 2019;17(6):891-905.

review2019
3

Martinez LA, Thompson PB, Anderson KL. Novel therapeutic approaches in thrombotic disorders due to platelet dysfunction: a phase III clinical trial. Thromb Res. 2022;210:78-89.

clinical_trial2022
4

Roberts MA, Kim NG, Lee HS. Antiplatelet therapy outcomes in constitutional platelet anomalies: meta-analysis of randomized controlled trials. Circulation. 2020;142(11):1023-1036.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Thrombotic Disorder Due To A Constitutional Platelet Anomaly C5680686. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy